Dapagliflozin: a potential lifesaver for “heart failure patients with mildly reduced or preserved ejection fraction” in the world

Dear Editor, According to the "World Health Organization (WHO)," approximately 17.9 million people die each year from cardiovascular diseases like heart failure, making it the second-leading cause of death in the world after cancer. (1) Consequently, treatment and care for heart failure...

Full description

Bibliographic Details
Main Authors: Faizan Shafqat Ali Bijarani, Ahsan Nazeer, Bisma Shaikh
Format: Article
Language:English
Published: Pakistan Medical Association 2023-11-01
Series:Journal of the Pakistan Medical Association
Online Access:https://www.ojs.jpma.org.pk/index.php/public_html/article/view/9968